Cargando…
Risque de méthémoglobinémie après application d'Emla® chez les prématurés
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Masson SAS
1995
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133316/ https://www.ncbi.nlm.nih.gov/pubmed/7496464 http://dx.doi.org/10.1016/0929-693X(96)89906-4 |
| _version_ | 1783517605916573696 |
|---|---|
| author | Gourrier, E. Leraillez, J. |
| author_facet | Gourrier, E. Leraillez, J. |
| author_sort | Gourrier, E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7133316 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1995 |
| publisher | Published by Elsevier Masson SAS |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71333162020-04-08 Risque de méthémoglobinémie après application d'Emla® chez les prématurés Gourrier, E. Leraillez, J. Arch Pediatr Article Published by Elsevier Masson SAS 1995-10 2001-10-30 /pmc/articles/PMC7133316/ /pubmed/7496464 http://dx.doi.org/10.1016/0929-693X(96)89906-4 Text en Copyright © 1995 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Gourrier, E. Leraillez, J. Risque de méthémoglobinémie après application d'Emla® chez les prématurés |
| title | Risque de méthémoglobinémie après application d'Emla® chez les prématurés |
| title_full | Risque de méthémoglobinémie après application d'Emla® chez les prématurés |
| title_fullStr | Risque de méthémoglobinémie après application d'Emla® chez les prématurés |
| title_full_unstemmed | Risque de méthémoglobinémie après application d'Emla® chez les prématurés |
| title_short | Risque de méthémoglobinémie après application d'Emla® chez les prématurés |
| title_sort | risque de méthémoglobinémie après application d'emla® chez les prématurés |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133316/ https://www.ncbi.nlm.nih.gov/pubmed/7496464 http://dx.doi.org/10.1016/0929-693X(96)89906-4 |
| work_keys_str_mv | AT gourriere risquedemethemoglobinemieapresapplicationdemlachezlesprematures AT leraillezj risquedemethemoglobinemieapresapplicationdemlachezlesprematures |